SMARCA1 and adenocarcinoma: In 477 adenocarcinomas of the stomach and gastroesophageal junction, 32% of cases demonstrated aberrant expression of the SWI/SNF complex, and SWI/SNF aberration emerged as an independent negative prognostic factor for overall survival [14].